JPRN-UMIN000044902
Recruiting
N/A
Effect of Dapagriflozin on renal dysfunction in patients with heart failure - Effect of Dapagriflozin on renal dysfunction in patients with heart failure
Conditionschronic heart failure
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- chronic heart failure
- Sponsor
- Mitsui Memorial Hospital
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Contraindications in the attached text
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Effects of dapagliflozin on renal function in patients with type 2 diabetes [Diamond study-4]patients with type 2 diabetesJPRN-UMIN000020185Diamond study group15
Active, Not Recruiting
Phase 1
The effect of treatment with Dapagliflozin on heart and kidney function after catheter based aortic valve replacement for aortic stenosisPatients with aortic stenosis undergoing trans catheter aortic valve replacement.MedDRA version: 20.0Level: LLTClassification code 10058186Term: Aortic valve stenosis and insufficiencySystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2021-004271-14-DKAarhus University Hospital, department of Cardiology104
Active, Not Recruiting
Phase 1
Effect of Dapagliflozin on myocardial and renal function following aortic valve stenosis interventioAortic stenosisTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]CTIS2024-514868-11-00Aarhus Universitetshospital106
Active, Not Recruiting
Phase 1
Effect of the dapagliflozin drug on the glomerular hyperfiltration in nondiabeticobese patients.This study aims to demonstrate the hypothesis that treatment with dapagliflozin 10mg lowers in at least 10-20% of measured glomerular filtration rate (mGFR) in non-diabetic obese patients with glomerular hyperfiltration.Therapeutic area: Diseases [C] - Symptoms and general pathology [C23]EUCTR2019-002262-12-ESHospital Universitari Germans Trias i Pujol60
Recruiting
Phase 4
Effect of empagliflozin on renal events in non-diabetic chronic kidney disease patientsChronic kidney disease.Chronic kidney disease (CKD)IRCT20211104052965N1Shahid Beheshti University of Medical Sciences458